Hypocarbia, also known as hypocapnia, is a decrease in alveolar and blood carbon dioxide (CO2) levels below the normal reference range of 35 mm Hg. CO2 is a metabolic product of the many cellular processes within the body involved in the processing of lipids, carbohydrates, and proteins. The primary organ systems responsible for regulating CO2 homeostasis are the pulmonary system and the renal system. Additionally, CO2 is regulated through the CO2/HCO3 pH buffering system. Aberrations that lead to hypocarbia typically also result in respiratory alkalosis.
At its root, hypocarbia is induced by either a decrease in CO2 production or an increase in CO2 loss. Since metabolic demand does not typically decrease in a way that meaningfully adjusts CO2 levels into hypocarbic levels, the primary occurrence is a loss of CO2 via the pH buffering system or changes in the pulmonary system. The pulmonary system is highly efficient in its removal of CO2 from the body through gas diffusion. This requires a diffusion gradient from the high concentration arteriolar blood into the relatively low concentration environmental air. This gradient is maintained through continually washing away CO2 from the alveolar space, regardless of the absolute PACO2 concentration. As such, the CO2 gradients are developed and maintained where PaCO2 in arterial blood is directly proportional to the rate of metabolic CO2 production and inversely related to the rate of CO2 elimination by the lung via increased alveolar ventilation. Alveolar ventilation is the removal of alveolar air into the environment, defined as the expired minute volume that reaches the alveoli and is determined by minute ventilation and the ratio of dead space to tidal volume. Mathematically, this relationship is determined as:
Where VCO2 is the metabolic production of CO2, VA is alveolar ventilation, VE is minute ventilation, VD is dead space ventilation, RR is the respiratory rate, and TV is tidal volume.
Through these relationships, one can conclude that respiratory rate and tidal volume are the two components of ventilation that are physiologically or artificially controlled to moderate CO2 elimination. Subsequently, the etiologies that induce hypocarbia are any disease that increases ventilation rate or tidal volume. More commonly, the increased respiratory rate is the culprit. A wide variety of illnesses may induce this.
In almost every scenario, hypocarbia is synonymous with respiratory alkalosis as they are both induced by a process involving hyperventilation. These include:
Central sources are head injury, stroke, hyperthyroidism, anxiety-hyperventilation, pain, fear, stress, drugs, medications such as salicylates, and various toxins.
Hypoxic stimulation leads to hyperventilation in an attempt to correct hypoxia at the expense of CO2 loss.
Pulmonary causes include pulmonary embolisms, pneumothorax, pneumonia, and acute asthma or chronic obstructive pulmonary disease (COPD) exacerbations.
The frequency and distribution of illness is variable dependent on the exact etiology of the disease. Likewise, the morbidity and mortality are linked to the exact etiology of the inciting disease. In general, younger patients have better outcomes. The most common acid-base disturbance observed in critical patients is respiratory alkalosis.
Hypocarbia is a result of hyperventilation. Increased ventilation to the alveolar space quickly removes gaseous CO2. This increases the diffusion gradient of CO2 from blood to alveoli. Subsequently, CO2 is more readily removed from the body. There are virtually no mechanisms outside of decreasing respiratory rate to regulate this loss. The partial pressure of carbon dioxide (PaCO2) is maintained between 35-45 mmHg with the help of feedback regulators. Central chemoreceptors (in the brain) and peripheral chemoreceptors (in the carotid bodies) sense the concentration of hydrogen and influence ventilation to regulate pH and PaCO2. For instance, if these receptors sense an increased concentration of hydrogen ions, ventilation is escalated to wash off CO2. If hyperventilation is persistent, it eventually leads to hypocapnia because alveolar ventilation exceeds the amount of CO2 being produced.
The estimation of change in pH with hyperventilation can be done with the help of the following:
Clinical presentation of hypocarbia depends on the duration, severity, and the underlying cause of the illness. Since the underlying mechanism behind all the etiologies of hypocapnia is hyperventilation, many patients present with a complaint of shortness of breath. The exact history and physical exam findings are highly variable as many pathologies induce respiratory change. These may include acute onset dyspnea, fever, chills, peripheral edema, orthopnea, weakness, chest pain, wheezing, hemoptysis, trauma, history of central line catheter, recent surgery, history of thromboembolic disease, history of asthma, history of COPD, acute focal neurological signs, abdominal pain, nausea, vomiting, tinnitus, or weight loss.
Cerebral vasoconstriction secondary to hypocarbia may present with neurological symptoms such as dizziness, confusion, seizures, and syncope. However, these symptoms only manifest in the absence of hypoxemia.
Hyperventilation may also lead to painful tingling in the hands and feet, numbness, and sweating of the hands.
Hypocarbia also hampers vitamin D metabolism leading to hypovitaminosis D, which may present as fibromyalgias and tetany.
Depending on the etiology, physical exam findings may vary significantly.
Tachypnea is a frequent finding at presentation, as many patients with hyperventilation syndrome are anxious and tachycardic. The only difference between acute and chronic hypocarbia is that in an acute setting, patients tend to have chest wall movements and increased breathing rate. In contrast, in chronic states, these findings may not be apparent.
There may be positive Trousseau, and Chvostek signs secondary to respiratory alkalosis, which causes decreased serum Calcium due to a shift of Calcium from the blood to albumin, which has become more negative in the alkalotic state.
Several pulmonary diseases often present with hyperventilation and respiratory alkalosis. In such instances, the physical findings on chest examination would depend on the underlying pathology. For example, coarse crackles in pneumonia, wheezes, and rhonchi in asthma, or fine crackles in left ventricular failure and interstitial lung diseases.
With a wide preliminary differential diagnosis list, evaluation should always begin with a thorough history and physical exam to focus on diagnostic considerations. In all cases, arterial blood gas is crucial to diagnose any pH imbalances. Serum electrolytes should be measured particularly sodium, potassium, magnesium, phosphate and calcium levels as aberrations in these may lead to further complications.
Bicarbonate concentration level declines by 2mEq/L for each decrease of 10 mmHg in the PaCO2 level in acute setting. However, in chronic cases, the bicarbonate level decreases by 5 mEq/L for each decline of 10 mmHg in the PaCO2 level. Nevertheless, bicarbonate levels usually never decline below 12 mmHg in compensated primary respiratory alkalosis.
In hypoxic patients, it is important to calculate the A-a gradient to determine the etiology and further diagnosis. If the A-a gradient is wide, be suspicious of pulmonary embolism and appropriately investigate the patient.
A chest x-ray is important in all patients as it helps discern an anatomical or infectious cause and may rule in/out pulmonary edema. If there is a clinical reason for it, chest CT can play a vital role in achieving a diagnosis
Treatment of hypocapnia is targeted at treating the underlying pathology to reduce the respiratory rate if possible. Historically treatment involved rebreathing into a paper bag to increase alveolar CO2. However, this has been shown to increase undesirable outcomes including mortality and is no longer recommended. In anxious patients, anxiolytics may be necessary. In an infectious disease, antibiotics targeting sputum or blood cultures are appropriate. In embolic disease, anticoagulation is necessary. Ventilator support may be necessary for patients with acute respiratory failure, acute asthma, or acute COPD exacerbation if they show signs of respiratory fatigue. In ventilator controlled patients, it may be necessary to reevaluate their ventilator settings to reduce respiratory rate. If hyperventilation is intentional, monitor the arterial or venous blood gas values closely. In severe cases, pH may be directly reduced using acidic agents; however, this is not routinely performed.
The differential diagnoses of hypocarbia are various and may involve nearly every organ system of the body. These etiologies may be physiological such as pregnancy or non-organic such as hyperventilation syndrome. Pathological causes that may result in hypocarbia include the following:
Hypocapnia is relatively benign and well tolerated by patients, as such the prognosis is linked to the underlying etiology and response to treatment.
Hypocarbia is typically occurs because of hyperventilation.
Hyperventilation typically occurs in response to an insult such as hypoxia, metabolic acidosis, pain, anxiety, or increased metabolic demand.
Hypocarbia results in respiratory alkalosis.
Respiratory alkalosis is not life-threatening. However, the underlying etiology may be. Always look for and treat the source of the illness.
Interventions to reduce pH directly are typically not necessary.
Hypocarbia or hypocapnia is a decrease in alveolar and blood carbon dioxide (CO2) levels below the normal reference range of 35 mm Hg. Aberrations lead to hypocarbia, typically resulting in respiratory alkalosis. It is important for the interprofessional team to recognize this condition and report to the team leader so that appropriate adjustments in care can be made. This will improve patient outcomes. [Level V]
|||Hypocapnia., Brusilow SW,, The New England journal of medicine, 2002 Nov 7 [PubMed PMID: 12422896]|
|||Stroev YI,Churilov LP, Hyperventilation Hypocapnia as The Leonardo da Vinci's Syndrome. Psychiatria Danubina. 2019 Mar; [PubMed PMID: 30946723]|
|||Severe diabetic ketoacidosis complicated by hypocapnic seizure., Majid A,Wheeler BJ,, Endocrinology, diabetes & metabolism case reports, 2017 [PubMed PMID: 28721220]|
|||Slow V̇O<sub>2</sub> kinetics in acute hypoxia are not related to a hyperventilation-induced hypocapnia., Keir DA,Pollock M,Thuraisingam P,Paterson DH,Heigenhauser GJF,Rossiter HB,Kowalchuk JM,, Respiratory physiology & neurobiology, 2018 Feb 22 [PubMed PMID: 29477729]|
|||A Quick Reference on Respiratory Alkalosis., Johnson RA,, The Veterinary clinics of North America. Small animal practice, 2017 Mar [PubMed PMID: 27939863]|
|||Brinkman JE,Sharma S, Physiology, Respiratory Alkalosis 2019 Jan; [PubMed PMID: 29489286]|
|||Altered mental status and complete heart block: an unusual presentation of aspirin toxicity., Aggarwal N,Kupfer Y,Chawla K,Tessler S,, BMJ case reports, 2013 Jun 10 [PubMed PMID: 23761511]|
|||The venous-arterial difference in CO<sub>2</sub> should be interpreted with caution in case of respiratory alkalosis in healthy volunteers., Morel J,Gergelé L,Dominé A,Molliex S,Perrot JL,Labeille B,Costes F,, Journal of clinical monitoring and computing, 2017 Aug [PubMed PMID: 27287759]|
|||Blood oxygen on Mount Everest., de Vries AP,Berend K,, The New England journal of medicine, 2009 Apr 30 [PubMed PMID: 19412985]|
|||Hypocapnia., Laffey JG,Kavanagh BP,, The New England journal of medicine, 2002 Jul 4 [PubMed PMID: 12097540]|
|||Sachan D,Goyal S, Association of Hypocapnia in Children with Febrile Seizures. Journal of pediatric neurosciences. 2018 Oct-Dec; [PubMed PMID: 30937077]|
|||A mechanism of central sleep apnea in patients with heart failure., Javaheri S,, The New England journal of medicine, 1999 Sep 23 [PubMed PMID: 10498490]|